T2 Biosystems
TTOO
$5.64
Share price
0.00%
Change (1 day)
1,988.89%
Change (1 year)
Categories
Operating Margin for T2 Biosystems (TTOO)
Operating Margin as of May 2024 (TTM): -252.10%
According to T2 Biosystems 's latest financial reports and stock price the company's current Operating Margin is -252.10%. At the end of 2021 the company had an Operating Margin of -175.50%.
Operating Margin history for T2 Biosystems from 2014 to 2022
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | -175.50% | -32.01% |
| 2020 | -258.12% | -63.54% |
| 2019 | -707.93% | 45.31% |
| 2018 | -487.17% | -63.59% |
| 2017 | -1,337.93% | -0.39% |
| 2016 | -1,343.24% | -16.57% |
| 2015 | -1,610.02% | -93.9% |
| 2014 | -26,378.15% | 240.45% |
| 2013 | -7,748.12% | -89.82% |
| 2012 | -76,078.95% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Aldeyra Therapeutics
ALDX | 0.00% | N/A | 🇺🇸 USA |
 CareDx CDNA | -24.00% | -90.48% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.